Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Cell Death Dis ; 15(8): 623, 2024 Aug 26.
Article in English | MEDLINE | ID: mdl-39187498

ABSTRACT

Retinal degeneration is a collection of devastating conditions with progressive loss of vision which often lead to blindness. Research on retinal microglial cells offers great therapeutic potential in deterring the progression of degeneration. This study explored the mechanisms underlying the TREM2-mediated protective function of activated microglial cells during retinal degeneration. N-methyl-N-nitrosourea (MNU)-induced retinal degeneration was established in C57BL/6 J (WT) and Trem2 knockout (Trem2-/-) mice. We discovered that MNU treatment led to the concurrent processes of photoreceptor apoptosis and microglia infiltration. A significant upregulation of disease-associated microglia signature genes was observed during photoreceptor degeneration. Following MNU treatment, Trem2-/- mice showed exacerbated photoreceptor cell death, decreased microglia migration and phagocytosis, reduced microglial PPARγ activation and CD36 expression. Pharmaceutical activation of PPARγ promoted microglial migration, ameliorated photoreceptor degeneration and restored CD36 expression in MNU-treated Trem2-/- mice. Inhibition of CD36 activity worsened photoreceptor degeneration in MNU-treated WT mice. Our findings suggested that the protective effect of microglia during retinal degeneration was dependent on Trem2 expression and carried out via the activation of PPARγ and the consequent upregulation of CD36 expression. Our study linked TREM2 signaling with PPARγ activation, and provided a potential therapeutic target for the management of retinal degeneration.


Subject(s)
CD36 Antigens , Membrane Glycoproteins , Microglia , PPAR gamma , Receptors, Immunologic , Retinal Degeneration , Animals , Mice , Apoptosis/drug effects , CD36 Antigens/metabolism , CD36 Antigens/genetics , Cell Movement , Membrane Glycoproteins/metabolism , Membrane Glycoproteins/genetics , Methylnitrosourea/toxicity , Mice, Inbred C57BL , Mice, Knockout , Microglia/metabolism , Microglia/pathology , Phagocytosis , Photoreceptor Cells/metabolism , Photoreceptor Cells/pathology , PPAR gamma/metabolism , Receptors, Immunologic/metabolism , Receptors, Immunologic/genetics , Retinal Degeneration/pathology , Retinal Degeneration/metabolism
2.
J Hazard Mater ; 473: 134586, 2024 Jul 15.
Article in English | MEDLINE | ID: mdl-38776811

ABSTRACT

The impact of plastic pollution on living organisms have gained significant research attention. However, the effects of nanoplastics (NPs) on retina remain unclear. This study aimed to investigate the effect of long-term polystyrene nanoparticles (PS-NPs) exposure on mouse retina. Eight weeks old C57BL/6 J mice were exposed to PS-NPs at the diameter of 100 nm and concentration of 10 mg/L in drinking water for 3 months. PS-NPs were able to penetrate the blood-retina barrier, accumulated at retinal tissue, caused increased oxidative stress level and reduced scotopic electroretinal responses without remarkable structural damage. PS-NPs exposure caused cytotoxicity and reactive oxygen species accumulation in cultured photoreceptor cell. PS-NPs exposure increased oxidative stress level in retinal pigment epithelial (RPE) cells, leading to changes of gene and protein expression indicative of compromised phagocytic activity and cell junction formation. Long-term PS-NPs exposure also aggravated light-induced photoreceptor cell degeneration and retinal inflammation. The transcriptomic profile of PS-NPs-exposed, light-challenged retinal tissue shared similar features with those of age-related macular degeneration (AMD) patients in the activation of complement-mediated phagocytic and proinflammatory responses. Collectively, these findings demonstrated the oxidative stress- and inflammation-mediated detrimental effect of PS-NPs on retinal function, suggested that long-term PS-NPs exposure could be an environmental risk factor contributing to retinal degeneration.


Subject(s)
Light , Mice, Inbred C57BL , Nanoparticles , Oxidative Stress , Polystyrenes , Retina , Retinal Degeneration , Retinal Pigment Epithelium , Animals , Polystyrenes/toxicity , Polystyrenes/chemistry , Retinal Degeneration/chemically induced , Retinal Degeneration/pathology , Nanoparticles/toxicity , Oxidative Stress/drug effects , Retina/drug effects , Retina/radiation effects , Retinal Pigment Epithelium/drug effects , Retinal Pigment Epithelium/pathology , Retinal Pigment Epithelium/metabolism , Reactive Oxygen Species/metabolism , Mice , Electroretinography , Male
3.
Adv Sci (Weinh) ; 11(20): e2304326, 2024 May.
Article in English | MEDLINE | ID: mdl-38544338

ABSTRACT

Chronic atrophic gastritis (AG) is initiated mainly by Helicobacter pylori infection, which may progress to stomach cancer following the Correa's cascade. The current treatment regimen is H. pylori eradication, yet evidence is lacking that this treatment is effective on later stages of AG especially gastric gland atrophy. Here, using AG mouse model, patient samples, gastric organoids, and lineage tracing, this study unraveled gastric stem cell (GSC) defect as a crucial pathogenic factor in AG in mouse and human. Moreover, a natural peptide is isolated from a traditional Chinese medicine that activated GSCs to regenerate gastric epithelia in experimental AG models and revitalized the atrophic gastric organoids derived from patients. It is further shown that the peptide exerts its functions by stabilizing the EGF-EGFR complex and specifically activating the downstream ERK and Stat1 signaling. Overall, these findings advance the understanding of AG pathogenesis and open a new avenue for AG treatment.


Subject(s)
Disease Models, Animal , Gastritis, Atrophic , Stem Cells , Gastritis, Atrophic/drug therapy , Gastritis, Atrophic/metabolism , Animals , Mice , Humans , Stem Cells/metabolism , Stem Cells/drug effects , Medicine, Chinese Traditional/methods , Peptides/pharmacology , Gastric Mucosa/metabolism , Gastric Mucosa/drug effects , Helicobacter Infections/drug therapy , Chronic Disease , Signal Transduction/drug effects
4.
J Ethnopharmacol ; 317: 116847, 2023 Dec 05.
Article in English | MEDLINE | ID: mdl-37356743

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Si-Wu Decoction (SWD) is a traditional Chinese medicine decoction. SWD is commonly used to treat blood deficiency syndrome. It is also used to treat some ulcerative colitis (UC) patients now, but the mechanism of action remains unclear. AIM OF THE STUDY: This study explored the efficacy and mechanism of action of SWD in treating UC based on network pharmacology and related experimental validation. MATERIALS AND METHODS: Several databases were used to screen SWD for major active ingredients, targets of the ingredients, and UC disease genes. Cytoscape 3.8.2 software was used for topological analysis to construct the drug-compound-disease gene-target relationship network. The String database platform was used to construct the target protein interaction network. The DAVID (Database for Annotation, Visualization and Integrated Discovery) database was used to perform the GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment analysis for the key targets. DSS (Dextran Sulfate Sodium)-induced UC mouse model was used to evaluate the in-vivo activity of SWD. Western Blot analysis and quantitative polymerase chain reaction were performed to verify the targets in the related pathways. RESULTS: Network pharmacology revealed that the SWD targeted pathway network involved 12 core targets and 15 major pathways. SWD may play a part by targeting key targets such as nuclear factor-kappaB (NF-κB), Janus kinase (JAK)-signal transducer and activator of transcription 3 (STAT3) pathway, and several mitogenic pathways. We showed that SWD largely restored the colorectal structure in UC model mice. Compared to the model group, the SWD group showed reduced infiltration of inflammatory cells. SWD significantly decreased the mRNA levels of IL-6 (Interleukin-6), TNF-α (Tumor necrosis factor-alpha), IL-1b (Interleukin-1beta) and other pro-inflammatory factors. Western Blot results showed that SWD concentration-dependently inhibited STAT3 and NF-κB activation in DSS-treated colon tissue. CONCLUSION: Our findings suggest that SWD treats UC by inhibiting STAT3 and NF-κB signaling pathways, reducing the expression of inflammatory cytokines, and improving epithelial repair in experimental colitis, thus shedding light on the mechanisms by which SWD exerts its effects on UC.


Subject(s)
Colitis, Ulcerative , Colitis , Drugs, Chinese Herbal , Animals , Mice , Colitis, Ulcerative/chemically induced , Colitis, Ulcerative/drug therapy , Network Pharmacology , NF-kappa B , Drugs, Chinese Herbal/pharmacology , Drugs, Chinese Herbal/therapeutic use , Tumor Necrosis Factor-alpha , Molecular Docking Simulation
SELECTION OF CITATIONS
SEARCH DETAIL